Patent details

Basic Information

Publication number:

EP1432408

PCT Application Number:

PCT/EP/2002/010890

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP027746619

PCT Publication Number:

WO/2003/028705

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITIONS COMPRISING COLLOIDAL SILICON DIOXIDE

French Title of Invention:

COMPOSITIONS PHARMACEUTIQUES A BASE DE DIOXYDE DE SILICIUM COLLOIDAL

German Title of Invention:

PHARMAZEUTISCHE ZUBEREITUNGEN ENTHALTEND KOLLOIDALES SILICIUMDIOXID

SPC Number:

Dates

Filing date:

27/09/2002

Grant date:

27/10/2010

EP Publication Date:

27/10/2010

PCT Publication Date:

10/04/2003

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

30/06/2004

EP B1 Publication Date:

27/10/2010

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

27/09/2018

Expiration date:

27/09/2022

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

13/03/2019

 

 

Name:

NOVARTIS INTERNATIONAL PHARMACEUTICAL AG

Address:

Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Name:

NOVARTIS PHARMA AG

Address:

Lichtstrasse 35, 4056, Basel, Switzerland (CH)

History of Owners

From:

26/01/2011

To:

13/03/2019

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:

Novartis Pharma GmbH

Address:

Brunner Strasse 59, 1230 Wien, Austria (AT)

Inventor

1

Name:

HAEBERLIN Barbara

Address:

Switzerland (CH)

2

Name:

HEUERDING Silvia

Address:

Switzerland (CH)

3

Name:

KRAMER Andrea

Address:

Germany (DE)

Licencee

Name:

N.V. Novartis Pharma S.A.

From:

27/03/2019

Address:

Medialaan 40, 1800, Vilvoorde, Belgium (BE)

To:

Priority

Priority Number:

0123400

Priority Date:

28/09/2001

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

A61K 9/20;

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2019/05

Publication date:

11/04/2019

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

MED

Bulletin edition number:

2019/06

Publication date:

06/05/2019

Description:

Section K : Modifications and recordals into the register

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20190000121A

Date Registered:

13/03/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

1

Name:

NOVARTIS PHARMA AG

Address:

Lichtstrasse 35, 4056, Basel, Switzerland (CH)

2

Name:

NOVARTIS INTERNATIONAL PHARMACEUTICAL AG

Address:

Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Removed Pledgee

Name:

Address:

Licence

Change Kind/ Decision Type:

New licence registration

Deed Number:

RC20190000139H

Date Registered:

27/03/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Not Exclusive

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Luxembourg (LU)

Updated Licence Number:

Terminated Licence Number:

Added Licencee(s)

Name:

N.V. Novartis Pharma S.A.

Address:

Medialaan 40, 1800, Vilvoorde, Belgium (BE)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

08/09/2017

Last Annual Fee Paid Number:

16

Last Annual Fee Paid Amount:

230 Euro

Payer:

MARKS & CLERK LLP

Filing date	Document type	Number of pages
01/04/2019	Outgoing Correspondence	1
13/03/2019	Request For Change	6
04/02/2019	Outgoing Correspondence	1
27/03/2019	Request For Change	6
21/03/2019	Outgoing Correspondence	2